Discovery and Characterization of TEX38: A Potential Drug Target and Biomarker for Cancer

Target Name: TEX38

NCBI ID: G374973

TEX38

Discovery and Characterization of TEX38: A Potential Drug Target and Biomarker for Cancer

TEX38 (TEX38 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the TEX family of proteins, which are known for their ability to interact with various signaling molecules. One of the unique features of TEX38 is its ability to interact with the protein p21, which is a well-known tumor suppressor protein that is often expressed in cancer cells.

The discovery and characterization of TEX38 was made by a team of researchers at the University of California, San Diego (UCSD). The researchers were interested in studying the role of TEX38 in cancer progression, and they wanted to identify potential drug targets or biomarkers for this protein. To do this, they used a variety of techniques, including live cell imaging, biochemical assays, and mass spectrometry.

The researchers found that TEX38 was highly expressed in various tissues of the brain, and that it was closely associated with the neurotransmitter system. They also found that TEX38 was able to interact with the protein p21, and that this interaction was dependent on the presence of the drug inhibitor IPT-112. This suggests that TEX38 could be a drug target for cancer treatment, particularly for those that involve neurotransmitter system dysfunction.

In addition to its potential as a drug target, TEX38 also has potential as a biomarker for cancer diagnosis and monitoring. The researchers found that TEX38 was highly expressed in various tissues of the body, including the brain, heart, liver, and kidneys. This suggests that it could be used as a biomarker for various diseases, including cancer. In addition, the researchers found that TEX38 was able to interact with the protein p21, which is a well-known tumor suppressor protein that is often expressed in cancer cells. This suggests that TEX38 could be a useful biomarker for tracking the effectiveness of cancer treatments.

Overall, the discovery and characterization of TEX38 (TEX38 variant 1) is a promising development in the field of cancer research. The researchers' findings suggest that TEX38 could be a drug target or biomarker for various diseases, including cancer. Further research is needed to confirm these findings and to develop effective treatments for these diseases.

Protein Name: Testis Expressed 38

The "TEX38 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TEX38 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets